287 related articles for article (PubMed ID: 38028548)
1. Machine learning combining multi-omics data and network algorithms identifies adrenocortical carcinoma prognostic biomarkers.
Martin-Hernandez R; Espeso-Gil S; Domingo C; Latorre P; Hervas S; Hernandez Mora JR; Kotelnikova E
Front Mol Biosci; 2023; 10():1258902. PubMed ID: 38028548
[No Abstract] [Full Text] [Related]
2. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
4. Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis.
Liu P; Tian W
PeerJ; 2020; 8():e9654. PubMed ID: 32832275
[TBL] [Abstract][Full Text] [Related]
5. Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning.
Marquardt A; Landwehr LS; Ronchi CL; di Dalmazi G; Riester A; Kollmannsberger P; Altieri B; Fassnacht M; Sbiera S
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572898
[TBL] [Abstract][Full Text] [Related]
6. A transcription factor signature predicts the survival of patients with adrenocortical carcinoma.
Zhao J; Liu B; Li X
PeerJ; 2021; 9():e12433. PubMed ID: 34966575
[TBL] [Abstract][Full Text] [Related]
7. Comparison of five supervised feature selection algorithms leading to top features and gene signatures from multi-omics data in cancer.
Bhadra T; Mallik S; Hasan N; Zhao Z
BMC Bioinformatics; 2022 Apr; 23(Suppl 3):153. PubMed ID: 35484501
[TBL] [Abstract][Full Text] [Related]
8. A novel prognostic model based on multi-omics features predicts the prognosis of colon cancer patients.
Yang H; Jin W; Liu H; Wang X; Wu J; Gan D; Cui C; Han Y; Han C; Wang Z
Mol Genet Genomic Med; 2020 Jul; 8(7):e1255. PubMed ID: 32396280
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic metabolic genes in adrenocortical carcinoma and establishment of a prognostic nomogram: A bioinformatic study.
Chen Q; Ren Z; Liu D; Jin Z; Wang X; Zhang R; Liu Q; Cheng W
Medicine (Baltimore); 2021 Dec; 100(50):e27864. PubMed ID: 34918636
[TBL] [Abstract][Full Text] [Related]
10. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y
Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643
[TBL] [Abstract][Full Text] [Related]
11. Identification of the ferroptosis regulator HELLS with prognostic value for adrenocortical carcinoma based on integrated analysis and experimental validation.
Liu Z; Xie Y; Liu S; Shen S; Zhu Y; Gou Q
Gland Surg; 2023 Sep; 12(9):1251-1270. PubMed ID: 37842529
[TBL] [Abstract][Full Text] [Related]
12. Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC).
Yuan K; Zeng R; Deng P; Zhang A; Liu H; Wang N; Tang Y; Yin Z; Liu H
Int J Gen Med; 2022; 15():1471-1483. PubMed ID: 35210821
[TBL] [Abstract][Full Text] [Related]
13. Identification of Four Novel Prognostic Biomarkers and Construction of Two Nomograms in Adrenocortical Carcinoma: A Multi-Omics Data Study
Yi X; Wan Y; Cao W; Peng K; Li X; Liao W
Front Mol Biosci; 2022; 9():878073. PubMed ID: 35693556
[No Abstract] [Full Text] [Related]
14. Revolutionary multi-omics analysis revealing prognostic signature of thyroid cancer and subsequent in vitro validation of SNAI1 in mediating thyroid cancer progression through EMT.
Jin X; Fu C; Qi J; Chen C
Clin Exp Med; 2024 Jun; 24(1):127. PubMed ID: 38869635
[TBL] [Abstract][Full Text] [Related]
15. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
Ji D; Zhong R; Fan S
Biomed Res Int; 2022; 2022():8740408. PubMed ID: 35647181
[TBL] [Abstract][Full Text] [Related]
17. Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma.
Li J; Jia Y; Tang L; Zhang R; Zhang Y
Front Genet; 2022; 13():948353. PubMed ID: 36092868
[No Abstract] [Full Text] [Related]
18. Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling.
Chierici M; Bussola N; Marcolini A; Francescatto M; Zandonà A; Trastulla L; Agostinelli C; Jurman G; Furlanello C
Front Oncol; 2020; 10():1065. PubMed ID: 32714870
[TBL] [Abstract][Full Text] [Related]
19. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
[TBL] [Abstract][Full Text] [Related]
20. Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical data.
Rashid MM; Selvarajoo K
Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38904542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
